Navigation Links
New drug strategy attacks resistant leukemia and lymphoma
Date:5/29/2012

BOSTON--Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.

The strategy could pave the way for much needed new therapies to treat relapsed and refractory blood cancers, which are difficult to cure because their cells deploy strong protein "deflector shields" to neutralize the cell death signals that chemotherapy agents used against them initially, say the researchers.

The prototype compound, called a "stapled BIM BH3 peptide," is designed to disable the cancer's defenses by hitting a family of protein targets that regulate cell death.

In proof-of-concept studies in mice with transplanted, drug-resistant leukemia tumors, the compound alone suppressed cancer growth, and when paired with other drugs, showed synergistic anti-cancer activity, say researchers led by Loren Walensky, MD, PhD, of Dana-Farber/Children's Hospital Cancer Center.

Their paper has been posted online by the Journal of Clinical Investigation and will appear in the journal's June issue. Walensky is the senior author and James LaBelle, MD, PhD, is the first author.

A cell's "fate" when and whether it lives or dies depends on a tug-of-war between pro-death and anti-death forces within the cell that serve as a check-and-balance system to maintain orderly growth. The system is regulated by the BCL-2 family of proteins, which contains both pro-death and pro-survival members.

When cells are no longer needed or are damaged beyond repair, the body activates pro-death BCL-2 proteins to shut down mitochondria the power plants of the cell resulting in an orchestrated cellular destruction known as apoptosis, or programmed cell death.

Many cell-killing cancer treatments work by triggering these "executioner proteins" t
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Strategy discovered to activate genes that suppress tumors and inhibit cancer
2. Discovery suggests new combination therapy strategy for basal-like breast cancers
3. White House Drug Policy Shifts Strategy
4. Scripps research scientists illuminate cancer cells survival strategy
5. Scientists report first step in strategy for cell replacement therapy in Parkinsons disease
6. Novel strategy stymies SARS et al.
7. UCSF tapped for US National AIDS Strategy initiative
8. Federal government releases environmental, health, and safety research strategy for nanotechnology
9. Miriam Hospital researchers pilot new acute hepatitis C screening strategy for HIV-infected patients
10. Strategy for improving health care for uninsured, low-income, and minorities in the US
11. New strategy likely to speed drug development for rare cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New drug strategy attacks resistant leukemia and lymphoma
(Date:2/26/2015)... Falls Church, VA (PRWEB) February 26, 2015 ... Medical Devices:, Understanding the FDA’s Position and Best ... April 14-15, 2015 – Bethesda, MD, http://www.fdanews.com/SoftwareAndCybersecurity ... renowned expert Fubin Wu — has been specifically ... to achieve compliance and effectively assure medical device ...
(Date:2/26/2015)... Deerfield, IL (PRWEB) February 26, 2015 ... present during adolescence and young adulthood. In response ... age group, and in support of National Eating ... and Medicine (SAHM) presents new evidence-based recommendations for ... adolescents and young adults, including a new approach ...
(Date:2/26/2015)... Body Well Therapy, a multi-regional provider of on-site ... quality mobile massage services to individuals and businesses ... United States. The company has experienced steady growth since 2005 ... sets its sights on additional major market expansion of it’s ... “We’ve come a long way since our founding in 2005 ...
(Date:2/26/2015)... February 26, 2015 It is no secret that ... have long shown that sleep improves the immune system, allows the ... and even helps a person lose weight. The message is ... Time is crunched and people try to fit more and ... weighs heavily on the mind and caffeine and alcohol are simply ...
(Date:2/26/2015)... With this upcoming launch on Dish ... the goal of offering their target audience of sports ... innovative and appealing content combined with opportunities to purchase ... and Reebok. SSN will also offer a variety of ... gear, travel services and other merchandise that supports an ...
Breaking Medicine News(10 mins):Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 4Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 2Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 3Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 2Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 3Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 4Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 5Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 6Health News:Sports Shop Network Announces Its March 28, 2015 U. S. Launch on Dish Network 2
... Jan. 14 The National Cancer Coalition (NCC) ... a pilot program to assist cancer patients in ... Mylotarg(TM) (gemtuzumab ozogamicin for injection) and Neumega(TM) (oprelvekin). ... Health Ministry participated in a hand-over event held ...
... fewer problems and a much higher quality of life if ... weeks after being discharged from hospital, according to research in ... . , During the two-year study, researchers from Umea University ... who had attended the same emergency department after an accident. ...
... This press release is available in French . ... a new protein in the progression of breast cancer. According ... the University of Alberta, published in the Journal of ... in cancer cell growth and the spread of tumours. Targeting ...
... ChicagoCHICAGO, Jan. 14 Euro RSCG Life LM&P, ... announce that their Chicago-based agency has been assigned ... to working with Euro RSCG Life LM&P to ... support to new and expectant moms and contribute ...
... -- China-Biotics, Inc.,(Nasdaq: CHBT ) ... in the manufacture, research, development, marketing and,distribution ... signed contracts,with four food manufacturers -- Shanghai ... Dairy Industry Co., Ltd. ("Huwa Dairy"), Qinghai ...
... Coconut Scrub Added to Specialty Line for Tweens and ... offers girls of all ages clarifying products that are ... cause redness and irritation. The products include the Everyday ... all of which will be debuting at the New ...
Cached Medicine News:Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:Telephone support after traffic accidents reduces problems and improves quality of life 2Health News:Telephone support after traffic accidents reduces problems and improves quality of life 3Health News:Euro RSCG Life LM&P Chicago Announces New Assignment From Lansinoh 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 4Health News:Glory for Girls Announces All-Natural Clarifying Products for Clear and Radiant Skin 2
(Date:2/26/2015)... ELMSFORD, N.Y. , Feb. 26, 2015 /PRNewswire/ ... year at the Clearwater Beach Hilton to ... ultrasound technology to plant reliability professionals from around ... together a stellar collection of leaders in the ... that the demand for excellence continues with this ...
(Date:2/26/2015)... 2015   Coverall North America, Inc. , a ... 30 Years of Clean, a major milestone that marks ... started in 1985 as a three-person company headquartered in ... now a leading global brand in the commercial cleaning ... have remained consistent: To promote economic growth and independence ...
(Date:2/26/2015)... Feb. 26, 2015   HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... of $73.2 million for the fourth quarter ended December ... in revenue for the same period of 2013.  For ... $278.4 million, a 34% increase compared to revenue of ...
Breaking Medicine Technology:UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2Coverall Celebrates 30 Years of Clean 2Coverall Celebrates 30 Years of Clean 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12
... Trial to Further Assess Feasibility of Dose-sparing and ... Single-Dose Vaccination Against H5N1 Flu -, GAITHERSBURG, ... announced that it has received approval from the,Department of Health ... immunostimulant adjuvant patch for use with an injected H5N1,influenza vaccine. ...
... Show Glioblastoma Killing in the Presence of ... Dexamethasone in Mouse Tumor Model, SAN DIEGO, ... the presentation of positive data in a mouse,tumor model from its ... and usually fatal brain,cancer. The data were presented in the New ...
Cached Medicine Technology:Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 2Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 3Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 2Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 3Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 4Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 5
... IMMULITE 1000 immunoassay system features an ... robust hardware and excellent assay performance. ... and accommodates onboard dilutions, positive sample ... Worldwide, IMMULITE 1000 (and its predecessor, ...
... Immunoassay Analyzer that fits in any lab environment. ... 16 X 21 inches and weighs approximately 60 ... office laboratories, work stations for small hospitals, STAT ... a dedicated system for specialty testing. With a ...
... ECi brings true automation and continuous ... Highly sensitive assays for thyroid, anemia, ... metabolism testing are currently available, with ... Vitros ECi can simultaneously process 60 ...
... Therapeutic Drug Monitoring Market in 1981 with ... use today, this system uses technology known ... serum drug concentration in a patient. Therapeutic ... diseases, often exhibit a narrow therapeutic range ...
Medicine Products: